Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

AAD 2024 Insights: What's New In Nail Tumors

AAD 2024

J. Dominguez-Cherit

Year in Review: Bowen Diseases and Squamous Cell Carcinoma of the Na…

2024 Year in Review

J. Dominguez-Cherit

EADV 2024 Insights: Dermatology in Skin of Color Patients - Challeng…

EADV 2024 Insights

N. Benmehidi

AAD 2024 Insights: Immunomodulators in Non-Melanoma Skin Cancer

AAD 2024

V. Patel

Oncolytic Viral Therapies in the Treatment of Melanoma and Other Ski…

Melanoma Research Foundation

G. In

Molecular vs. Multidisciplinary Tumour Boards in Skin Cancers

Alberto Cunquero

Year in Review: Updates in Non-Melanoma Skin Cancers

Dana-Farber Cancer Institute

K. Khaddour

Neoadjuvant Immunotherapy in Advanced cSCC

Vishal Patel

EADV 2023 Insights: Non-Melanoma Skin Cancer Management in Organ Tra…

EADV 2023 Insights

G. Hofbauer

Neoadjuvant IO: Non-Melanoma Skin Cancer

ImmunoTherapy Bridge 2023

N. Gross

Non-Melanoma Skin Cancers

ImmunoTherapy Bridge 2023

P. A. Ascierto

ESMO 2023 Insights: "Neoadjuvant Cemiplimab for Stage II to IV CSCC …

Insights from 2023 ESMO Annual Meeting

N. Gross

Management of High Risk Squamous Cell Carcinoma

NYU Langone

M. L. Stevenson

Updates in non-Melanoma Skin Cancer

Head and Neck Symposium: Skin Malignancies Update

S. Daveluy

Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Prof. Chalid Assaf

68 y/o Male With Moderately Differentiated Squamous Cell Carcinoma: …

Winship Melanoma and Cutaneous Oncology Symposium

C. Barker, T. Blalock, J. Choi, N. Kounalakis

2023 ASCO® Direct Philadelphia: Melanoma Updates

Total Health

M. Orloff

Updated in The Treatment of Immune-Related Adverse Events of Immunot…

Cleveland Clinic Dermatology & Plastic Surgery Institute

L. Korb Ferris

Best of SITC 2023 for Clinical Development and IO Trials

ImmunoTherapy Bridge 2023

P. A. Ascierto